Takeda Pharmaceutical Company Limited
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
Last updated:
Abstract:
The present invention provides a compound useful as an agent for the prophylaxis or treatment of neurodegenerative disease and the like, or a salt thereof. The present invention relates to a compound represented by the formula ##STR00001## wherein each symbol is as defined in the specification, or a salt thereof.
Status:
Grant
Type:
Utility
Filling date:
20 Jul 2020
Issue date:
16 Nov 2021